Cike Peng

Cike Peng has a diverse work experience spanning from 2007 to 2022. In 2007, they interned as a Resident at Beijing Shijitan Hospital. In 2009, they were an Intern at Beijing Center of Disease Control and Prevention (CDC) and a Public Relations Intern at Ruder Finn. In 2010, they were a CTL Assistant at Novartis Institutes for BioMedical Research. From 2011 to 2016, they were a PhD Student at DKFZ - German Cancer Research Center, a Clinical Research Specialist at Medtronic, a Sr. Research Scientist, HEOR/RWE and Health Economics and Outcomes Research Scientist at \u793c\u6765. In 2020, they were a Sr. Associate at Pivotal Bioventure China and a Director, Medical Strategy and Real-World Evidence at Happy Life Technology (HLT). Currently, they are an Associate Director Business Development at Asieris Pharmaceuticals.

Cike Peng received a Bachelor of Medicine in Preventive Medicine and Public Health from Peking University in 2009. Cike then obtained a Master of Medical Sciences in Toxicology from the same university in 2011. In the same year, they also received a PhD in Epidemiology from the DKFZ German Cancer Research Center and a Dr.sc.hum in Breast Cancer Biomarker Discovery and Validation from Heidelberg University. In 2015, they obtained a European Business Competence Licence - Level A from the Kuratorium Wirtschaftskompetenz für Europa.